Topical Minoxidil Improves the Quality of Life in Females with Androgenetic Alopecia
January 2014
in “
Journal of Clinical Dermatology
”
New to Minoxidil? There is a guide in the encyclopedia. Read the guide → Studysummary In this study, topical minoxidil significantly improved the quality of life for females with androgenic alopecia, as measured by both the dermatology life quality index and a visual analog scale. Our plain-language summary of this paper — not a Tressless recommendation.
The study surveyed 125 female patients with androgenetic alopecia (AGA) to assess the impact of topical minoxidil on their quality of life (QOL). Using the visual analog scale (VAS) and dermatology life quality index (DLQI), the study found that AGA severity negatively affected QOL. After 12 months of minoxidil treatment, 31 patients showed significant improvements in both VAS and DLQI scores, indicating enhanced QOL. The study concluded that topical minoxidil improved the QOL in female AGA patients, although the improvement was not linked to the therapeutic efficiency of the treatment.
